International Journal of Drug Policy
Volume 21, Issue 3 , Pages 255-258, May 2010

Expanding the reach of harm reduction in Thailand: Experiences with a drug user-run drop-in centre

  • Thomas Kerr

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 - 1081 Burrard Street, Vancouver BC, V6Z 1Y6 Canada
    • Department of Medicine, University of British Columbia, Vancouver, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +1 604 806 9116; fax: +1 604 806 9044.
  • ,
  • Kanna Hayashi

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 - 1081 Burrard Street, Vancouver BC, V6Z 1Y6 Canada
  • ,
  • Nadia Fairbairn

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 - 1081 Burrard Street, Vancouver BC, V6Z 1Y6 Canada
  • ,
  • Karyn Kaplan

      Affiliations

    • Thai AIDS Treatment Action Group, Thailand
  • ,
  • Paisan Suwannawong

      Affiliations

    • Thai AIDS Treatment Action Group, Thailand
  • ,
  • Ruth Zhang

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 - 1081 Burrard Street, Vancouver BC, V6Z 1Y6 Canada
  • ,
  • Evan Wood

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 - 1081 Burrard Street, Vancouver BC, V6Z 1Y6 Canada
    • Department of Medicine, University of British Columbia, Vancouver, Canada

Received 29 April 2009; received in revised form 8 July 2009; accepted 7 August 2009. published online 22 September 2009.

Abstract 

Background

Despite an ongoing epidemic of HIV among Thai people who inject drugs (IDU), Thailand has failed to implement essential harm reduction programmes. In response, a drug user-led harm reduction centre opened in 2004 in an effort to expand reduction programming in Thailand.

Methods

We examined experiences with the Mitsampan Harm Reduction Centre (MSHRC) among IDU participating in the Mitsampan Community Research Project (Bangkok). Multivariate logistic regression was used to identify factors associated with MSHRC use. We also examined services used at and barriers to the MSHRC.

Results

252 IDU participated in this study, including 66 (26.2%) females. In total, 74 (29.3%) participants had accessed the MSHRC. In multivariate analyses, MSHRC use was positively associated with difficulty accessing syringes (Adjusted Odds Ratio [AOR]=4.05; 95% Confidence Interval [CI]: 1.67–9.80), midazolam injection (AOR=3.25; 95%CI: 1.58–6.71), having greater than primary school education (AOR=1.88; 95%CI: 1.01–3.52), and was negatively associated with female gender (AOR=0.20; 95%CI: 0.08–0.50). Forms of support most commonly accessed included: syringe distribution (100%), food and a place to rest (83.8%), HIV education (75.7%), and safer injecting education (66.2%). The primary reason given for not having accessed the MSHRC was “didn’t know it existed.”

Conclusion

The MSHRC is expanding the scope of harm reduction in Thailand by reaching IDU, including those who report difficulty accessing sterile syringes, and by providing various forms of support. In order to maximise its benefits, efforts should be made to increase awareness of the MSHRC, in particular among women.

Keywords: Injection drug use, Thailand, Peer interventions

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(09)00114-5

doi:10.1016/j.drugpo.2009.08.002

International Journal of Drug Policy
Volume 21, Issue 3 , Pages 255-258, May 2010